COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

vartracker: an end-to-end tool for pathogen longitudinal variant analysis and visualisation
Foster, C. S. P., Rawlinson, W. D.
10.64898/2026.05.06.723370 — Posted: 2026-05-08
Determinants and long-term outcomes of COVID-19 undervaccination: a cohort study of 6.8 million individuals in Lombardy, Italy
Corbetta, A., Logan, K. M., Ieva, F., Di Angelantonio, E.
10.64898/2026.05.06.26352509 — Posted: 2026-05-07
SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation
Lacasse, E., Dubuc, I., Leclerc, J., Gravel, A., Gudimard, L., Joly-Beauparlant, C., Faure, M., Fortin, P., Blanchet, M.-R., Droit, A., Flamand, L.
10.64898/2026.05.06.723222 — Posted: 2026-05-07
Functional Landscape of Motifs within the Sarbecovirus Spike Cytoplasmic Tail
Zhou, S., Chen, C., Liu, C., Zheng, X., Shi, L., Ma, L., Cheng, P., Wang, Q., Liu, L.
10.64898/2026.05.06.723231 — Posted: 2026-05-07
The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2
Zhang, L., Chen, N., Eichmann, A., Nehlmeier, I., Hisner, R., Happle, C., Behrens, G. M. N., Hoffmann, M., Pöhlmann, S. H.
10.64898/2026.05.04.722688 — Posted: 2026-05-07
Inequalities in early childhood developmental concerns before, during and after the COVID-19 pandemic in Scotland: a retrospective cohort study
Hardie, I., Marryat, L., Murray, A., King, J., Okelo, K., Fenton, L., Boardman, J. P., Wilson, P., Wood, R. P., Auyeung, B.
10.64898/2026.04.30.26352025 — Posted: 2026-05-06
Identifying the determinants of health protective behaviors during the COVID-19 pandemic using machine learning: an analysis of six countries
Chevalier, J. M., Stellbrink, L. M., Steijvers, L., Wijnen, S., van Daalen, F., Kojan, L., Li, N., Jahn, B., Siebert, U., Calero Valdez, A., Hiligsmann, M., Crutzen, R., Dukers-Muijrers, N. H., Kretzschmar, M. E.
10.64898/2026.05.05.26352439 — Posted: 2026-05-06
Tocilizumab induces significant changes in longitudinal proteomes of blood serum from patients with severe COVID-19 pneumonia
Cordero, J., Bravo, G., Silva, P. H., Lozano, B., Rivas, E., Labra, V., Villalobos, D., Saldivia, P., Hernandez, M., Koch, E. S., Vargas, C., Nova-Lamperti, E., Barrera, N. P., Retamal, J.
10.64898/2026.05.05.723025 — Posted: 2026-05-06
Longitudinal analysis reveals myeloid cell contributions to neuroPASC pathogenesis
Tan, L., Lowery, S., Verma, A. K., Thurman, A. L., Sariol, A., Fain, C., Harty, J., Perlman, S.
10.64898/2026.05.04.722452 — Posted: 2026-05-06
The redesign of the molecular scaffold of viral ion channel blockers
Zsido, B., Mernyak, E., Földes, F., Kopasz, Z., Leiner, K., Madai, M., Zana, B., Kuczmog, A., Hetenyi, C.
10.64898/2026.04.30.721843 — Posted: 2026-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).